|
MAP1LC3B2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.427600E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.047600E-01 |
| Normal-vs-Stage2 |
4.181800E-01 |
| Normal-vs-Stage3 |
5.798000E-03 |
| Normal-vs-Stage4 |
1.512020E-01 |
| Stage1-vs-Stage2 |
7.427200E-01 |
| Stage1-vs-Stage3 |
1.010580E-01 |
| Stage1-vs-Stage4 |
7.816000E-01 |
| Stage2-vs-Stage3 |
2.175600E-01 |
| Stage2-vs-Stage4 |
6.510200E-01 |
| Stage3-vs-Stage4 |
3.843200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.907700E-02 |
| Normal-vs-AfricanAmerican |
5.528400E-01 |
| Normal-vs-Asian |
1.017630E-01 |
| Caucasian-vs-AfricanAmerican |
3.328000E-02 |
| Caucasian-vs-Asian |
8.838800E-01 |
| AfricanAmerican-vs-Asian |
7.290000E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.023800E-03 |
| Normal-vs-Female |
1.286640E-01 |
| Male-vs-Female |
5.442300E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.204600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.720400E-02 |
| Normal-vs-Age(61-80Yrs) |
7.136600E-03 |
| Normal-vs-Age(81-100Yrs) |
2.489400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.709800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.037800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.984600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.642600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.038800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.732000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.542600E-01 |
| Classical-VS-Follicular |
1.984500E-02 |
| Classical-VS-Other |
1.966220E-01 |
| Classical-VS-Normal |
2.142800E-01 |
| Tall-VS-Follicular |
5.121000E-01 |
| Tall-VS-Other |
3.590200E-01 |
| Tall-VS-Normal |
8.038500E-02 |
| Follicular-VS-Other |
6.752000E-01 |
| Follicular-VS-Normal |
1.275650E-02 |
| Other-VS-Normal |
8.021500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.996460E-02 |
| Normal-vs-N1 |
7.426100E-02 |
| N0-vs-N1 |
9.468000E-01 |
|
|
